Thomas Goedecke

Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 6

Top Venues

Clinical pharmacology and therapeutics

British journal of clinical pharmacology

Pharmacoepidemiology and drug safety

European Medicines Agency (EMA)

Ludwig-Maximilians-Universität München (PHD)

This page only lists publications with an associated author ORCID identifier.

Affiliation History

European Medicines Agency (EMA) Oct 01 2006

Netherlands

Principal Scientific Officer :: Pharmacovigilance and Epidemiology Department

Protina Pharmazeutische GmbH Jan 01 1998 - Sep 30 2006

Germany

Manager :: Medizinisch Wissenschaftliche Abteilung

Education History

Ludwig-Maximilians-Universität München Jan 01 1995 - Dec 31 1997

Germany

PHD :: Institut für Pharmazeutische Biologie

Publications

Thomas Goedecke, Liana Gross-Martirosyan, Nathalie Gault, Karin Seifert, Daniel R Morales, Priya Bahri, Valerie Strassmann, Martin Huber, Sabine Straus
Studying the Impact of European Union Regulatory Interventions for Minimising Risks From Medicines: Lessons Learnt and Recommendations. Pharmacoepidemiology and drug safety 33 (8) (2024)
Renske J Grupstra, Thomas Goedecke, Helga Gardarsdottir
Limitations Reported in Evaluating Effectiveness of Risk Minimization Measures in the EU during 2018-2021: A Qualitative Analysis of Industry-Sponsored Post-Authorization Safety Studies. Clinical pharmacology and therapeutics (2024)
Renske J Grupstra, Thomas Goedecke, Jet Scheffers, Valerie Strassman, Helga Gardarsdottir
Review of studies evaluating effectiveness of risk minimisation measures assessed by the European Medicines Agency between 2016 and 2021. Clinical pharmacology and therapeutics (2023)
Rosa Gini, Xavier Fournie, Helen Dolk, Xavier Kurz, Patrice Verpillat, François Simondon, Valerie Strassmann, Kathi Apostolidis, Thomas Goedecke
The ENCePP Code of Conduct: A best practise for scientific independence and transparency in noninterventional postauthorisation studies. Pharmacoepidemiology and drug safety 28 (4) (2019)
Thomas Goedecke, Daniel R Morales, Alexandra Pacurariu, Xavier Kurz
Response to 'Comment on 'Measuring the impact of medicines regulatory interventions - systematic review and methodological considerations' by Goedecke et al.' British journal of clinical pharmacology 84 (9) (2018)
Thomas Goedecke, Daniel R Morales, Alexandra Pacurariu, Xavier Kurz
Measuring the impact of medicines regulatory interventions - Systematic review and methodological considerations. British journal of clinical pharmacology 84 (3) (2017)

Thomas Goedecke.css-eqlu8i{font-size:small;padding-left:4px;}

Publication Activity (10 Years)

Top Topics

Top Venues

Thomas Goedecke